NYSE:TOVX | Cash Flow Statement | Theriva Biologics, Inc.

Complete source-backed cash-flow history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$3.22M
2026-03-31-$2.04M$24,000.00-$2.46M$3.87M
2025-12-31-$2M$27,000.00-$2.88M$0.00$0.00$8.46M
2025-09-30-$4.36M
2025-06-30-$13.06M
2025-03-31-$4.32M$26,000.00-$4.76M$3.07M
2024-12-31-$4.45M$27,000.00-$4.69M$0.00$0.00$7,000.00
2024-09-30-$7.73M
2024-06-30-$8.32M
2024-03-31-$5.17M$39,000.00-$4.88M
2023-12-31-$5.49M$39,000.00-$6.54M$56,000.00-$56,000.00-$1.46M
2023-09-30-$3.3M
2023-06-30-$5.08M
2023-03-31-$4.48M$32,000.00-$5.61M$8,000.00-$8,000.00-$55,000.00
2022-12-31-$6.45M$25,000.00-$5.37M$91,000.00-$91,000.00-$3.29M
2022-09-30-$4.49M
2022-06-30-$4.97M
2022-03-31-$4.27M$18,000.00-$4.9M$0.00-$4.28M-$1.38M
2021-12-31-$5.26M$13,000.00-$4.81M$0.00$0.00$0.00
2021-09-30-$3.27M
2021-06-30-$3.2M
2021-03-31-$2.54M$33,000.00-$3.33M$14,000.00-$14,000.00$74M
2020-12-31-$2.11M$32,000.00-$3.13M$5,000.00-$5,000.00$3.36M
2020-09-30-$2.1M
2020-06-30-$2.87M
2020-03-31-$2.96M$58,000.00-$4.96M$0.00$0.00$0.00
2019-12-31-$3.14M$58,000.00-$3.61M$0.00$0.00$0.00
2019-09-30-$5.12M
2019-06-30-$3.53M
2019-03-31-$3.51M$62,000.00-$4.22M$0.00$0.00
2018-12-31-$3.17M$65,000.00-$3.29M$7,000.00-$7,000.00$22.67M
2018-09-30-$3.68M
2018-06-30-$4.2M
2018-03-31-$2.32M$71,000.00-$6.08M$0.00$0.00$0.00
2017-12-31$2.85M$73,000.00-$3.93M$3,000.00-$3,000.00$1,000.00
2017-09-30-$10.92M
2017-06-30-$4.26M
2017-03-31-$2.85M$57,000.00-$6.01M$11,000.00-$11,000.00$435,000.00
2016-12-31-$2.38M$46,000.00-$10.38M$370,000.00-$370,000.00$25.26M
2016-09-30-$8.35M
2016-06-30-$5.68M
2016-03-31-$10.85M$37,000.00-$5.67M$44,000.00-$44,000.00$0.00
2015-12-31-$10.98M-$10.97M$44,000.00-$44,000.00$26,000.00
2015-09-30-$6.77M
2015-06-30-$13.62M
2015-03-31-$12.36M-$5.46M$18,000.00-$18,000.00$0.00
2014-12-31-$6.48M-$4.78M$5,000.00-$5,000.00$19.02M
2014-09-30-$4.91M
2014-06-30-$4.56M
2014-03-31-$3.84M-$3.47M$4,000.00-$4,000.00$4,000.00
2013-12-31-$4.22M-$2.7M$11,000.00-$11,000.00$12.2M
2013-09-30-$3.37M
2013-06-30-$2.5M
2013-03-31-$2.23M-$1.66M$3,000.00-$3,000.00$231,000.00
2012-12-31-$12.07M-$4.77M$3,000.00-$3,000.00$10.15M
2012-09-30-$1.93M
2012-06-30-$1.87M
2012-03-31-$1.2M-$1.42M$0.00$0.00$1.54M
2011-12-31-$3.19M-$731,000.00$0.00$2.79M$10,000.00
2011-09-30-$1.1M
2011-06-30-$1.68M
2011-03-31-$2.19M-$281,000.00$1,000.00$3.71M
2010-12-31-$870,425.00-$665,212.00$9,930.00-$9,390.00$18,276.00
2010-09-30-$732,835.00
2010-06-30$979,782.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$23.74M$108,000.00-$16.67M$35,000.00-$35,000.00$18.19M
2024-12-31-$25.65M$137,000.00-$16.94M$1,000.00-$1,000.00$5.5M
2023-12-31-$18.35M$135,000.00-$19M$202,000.00-$202,000.00$625,000.00
2022-12-31-$19.69M$85,000.00-$19.08M$116,000.00-$4.4M-$1.93M
2021-12-31-$14.27M$87,000.00-$12.89M$14,000.00-$14,000.00$74M
2020-12-31-$10.04M$201,000.00-$12.17M$9,000.00-$9,000.00$3.36M
2019-12-31-$15.3M$240,000.00-$13.87M$0.00$0.00$0.00
2018-12-31-$13.37M$272,000.00-$17.28M$7,000.00-$7,000.00$29.09M
2017-12-31-$15.17M$245,000.00-$20.2M$212,000.00-$212,000.00$18.48M
2016-12-31-$27.26M$157,000.00-$27.9M$569,000.00-$569,000.00$26.71M
2015-12-31-$43.74M$72,000.00-$38.89M$501,000.00-$501,000.00$42.68M
2014-12-31-$19.78M$20,000.00-$16.08M$48,000.00-$48,000.00$19.03M
2013-12-31-$12.32M$43,000.00-$7.72M$36,000.00-$36,000.00$12.43M
2012-12-31-$17.07M-$8.92M$10,000.00-$10,000.00$12.2M
2011-12-31-$8.15M-$2.88M$0.00-$75,000.00$6.98M
2010-12-31-$1.71M-$1.15M$12,000.00$65,000.00$1.01M
2009-12-31$1M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.